Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 7;4(1):257-80.
doi: 10.3390/cancers4010257.

Radiation therapy for the treatment of recurrent glioblastoma: an overview

Dante Amelio  1 , Maurizio Amichetti
Affiliations

Radiation therapy for the treatment of recurrent glioblastoma: an overview

Dante Amelio et al. Cancers (Basel). .

Abstract

Despite the therapeutic advances in neuro-oncology, most patients with glioblastoma ultimately experience local progression/relapse. Re-irradiation has been poorly viewed in the past, mainly due to the overestimated risk of side effects using conventional radiotherapy. To date, thanks to the improvement of several delivery techniques, together with improved imaging capabilities, re-irradiation is a viable salvage treatment option to manage such clinical scenario. A literature overview on the feasibility and efficacy of the different irradiation modalities for recurrent glioblastoma along with considerations on areas of improvement are provided.

PubMed Disclaimer

References

    1. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008;359:492–507. doi: 10.1056/NEJMra0708126. - DOI - PubMed
    1. Stupp R., Hegi M.E., Gilbert M.R., Chakravarti A. Chemoradiotherapy in malignant glioma: Standard of care and future directions. J. Clin. Oncol. 2007;25:4127–4136. doi: 10.1200/JCO.2007.11.8554. - DOI - PubMed
    1. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., Ludwin S.K., Allgeier A., Fisher B., Belanger K., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–466. doi: 10.1016/S1470-2045(09)70025-7. - DOI - PubMed
    1. Minniti G., Amelio D., Amichetti M., Salvati M., Muni R., Bozzao A., Lanzetta G., Scarpino S., Arcella A., Enrici R.M. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother. Oncol. 2010;97:377–381. doi: 10.1016/j.radonc.2010.08.020. - DOI - PubMed
    1. Barbagallo G.M., Jenkinson M.D., Brodbelt A.R. "Recurrent” glioblastoma multiforme, when should we reoperate? Br. J. Neurosurg. 2008;22:452–455. doi: 10.1080/02688690802182256. - DOI - PubMed

LinkOut - more resources